All Programs

Use the tool below to view all available Rheumatology Academy Series

Spot the Difference: Acute vs. Subacute Cutaneous Lupus
Spot the Difference: Acute vs. Subacute Cutaneous Lupus
Living Rheum
Spot the Difference: Acute vs. Subacute Cutaneous Lupus
Avery H. LaChance, MD, MPH, FAAD
- Avery H. LaChance, MD, MPH, FAAD
Key Advances in Rheumatology at CCR East 2026
Key Advances in Rheumatology at CCR East 2026
Living Rheum
Key Advances in Rheumatology at CCR East 2026
Louis Bessette MD, FRCP(C), MSc
- Louis Bessette MD, FRCP(C), MSc
The Cardiovascular Dimension of Psoriatic Arthritis
The Cardiovascular Dimension of Psoriatic Arthritis
Living Rheum
The Cardiovascular Dimension of Psoriatic Arthritis
IL-23 Inhibitors Show Broad PsA Control, with Important Gaps Remaining
IL-23 Inhibitors Show Broad PsA Control, with Important Gaps Remaining
Living Rheum
IL-23 Inhibitors Show Broad PsA Control, with Important Gaps Remaining
Minimal Disease Activity: A Practical Target in Psoriatic Arthritis
Minimal Disease Activity: A Practical Target in Psoriatic Arthritis
Living Rheum
Minimal Disease Activity: A Practical Target in Psoriatic Arthritis
Laura Coates, MBChB, MRCP, PhD
- Laura Coates, MBChB, MRCP, PhD
Measuring What Matters in Psoriatic Arthritis
Measuring What Matters in Psoriatic Arthritis
Living Rheum
Measuring What Matters in Psoriatic Arthritis
Laura Coates, MBChB, MRCP, PhD
- Laura Coates, MBChB, MRCP, PhD
Unpacking the Complexity of Psoriatic Arthritis
Unpacking the Complexity of Psoriatic Arthritis
Living Rheum
Unpacking the Complexity of Psoriatic Arthritis
Lawrence H. Brent
- Lawrence H. Brent
Diagnosing Psoriatic Arthritis: A Real-World Case
Diagnosing Psoriatic Arthritis: A Real-World Case
Living Rheum
Diagnosing Psoriatic Arthritis: A Real-World Case
Lawrence H. Brent
- Lawrence H. Brent
JAK Inhibitors in Psoriatic Arthritis: Reassessing Safety in the Real World
JAK Inhibitors in Psoriatic Arthritis: Reassessing Safety in the Real World
Living Rheum
JAK Inhibitors in Psoriatic Arthritis: Reassessing Safety in the Real World
Can FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
Can FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
AudioAbstracts
Can FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
Ryan Quigley
- Ryan Quigley
Navigating the Modern PsA Treatment Landscape
Navigating the Modern PsA Treatment Landscape
Living Rheum
Navigating the Modern PsA Treatment Landscape
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Living Rheum
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Steve Jackson, PharmD; Marc Scherlinger, MD, PhD
- Steve Jackson, PharmD
- Marc Scherlinger, MD, PhD
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Living Rheum
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Gary S. Firestein, MD
- Gary S. Firestein, MD
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Living Rheum
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Gary S. Firestein, MD
- Gary S. Firestein, MD
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
DermConsult
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Living Rheum
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Ryan Quigley
- Ryan Quigley

All Programs

Popular

CONTACT US

(866) 423-7849

CONTACT US

(866) 423-7849

All Programs

Popular

Title